Key facts
- This page summarizes Jonathan Sheena's Form 4 filing for Natera, Inc. (NTRA).
- 15 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 28 Feb 2025, 21:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.
Footnote F2
These shares were sold in multiple transactions at prices ranging from $157.4150 to $158.1900 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
Footnote F3
These shares were sold in multiple transactions at prices ranging from $158.72 to $159.58 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
Footnote F4
These shares were sold in multiple transactions at prices ranging from $160.5300 to $161.4450 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
Footnote F5
These shares were sold in multiple transactions at prices ranging from $161.64 to $162.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
Footnote F6
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
Footnote F7
Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Footnote F8
These shares were sold in multiple transactions at prices ranging from $158.33 to $159.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
Footnote F9
These shares were sold in multiple transactions at prices ranging from $160.2550 to $161.2500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
Footnote F10
These shares were sold in multiple transactions at prices ranging from $161.29 to $161.83 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
Footnote F11
These shares were sold in multiple transactions at prices ranging from $158.6850 to $159.2500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
Footnote F12
These shares were sold in multiple transactions at prices ranging from $160.43 to $161.29 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
Footnote F13
These shares were sold in multiple transactions at prices ranging from $161.4750 to $161.8200 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote